FEB 23, 2022 9:00 AM PST

Impacting Sepsis Outcomes Using MALDI-TOF: FDA-Cleared Application for Rapid Microbial ID Direct from Positive Blood Culture

Sponsored by: Bruker Daltonics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  February 23, 2022
Time: 09:00am (PST),  12:00pm (EST)
 
During this webinar we will present the Lahey four-year journey of using the MBT Sepsityper® solution for the rapid identification (ID) of microorganisms direct from positive blood culture (PBC). The focus will be on the recent implementation of the MBT Sepsityper Kit US IVD, the only FDA cleared MALDI-TOF based application available for rapid ID direct from PBC, in the clinical microbiology laboratory at Lahey Hospital and Medical Center. The presentation will discuss 1) the ease and benefits of implementing an FDA-cleared application, 2) how the MBT Sepsityper® workflow can be used as a rapid front-line method to identify a broad range of microorganisms, 3) how to decrease the use of expensive molecular applications on the blood culture bench with workflow suggestions, and 4) present actual case studies that demonstrate the clinical impact of a rapid ID direct from PBC using MBT Sepsityper® workflow. Finally in closing, please join the Q & A session where you can ask Felicia, a proven MBT Sepsityper expert, questions that you may have.
 
Learning Objectives
  • List (3) benefits of implementing an FDA-cleared application vs a laboratory developed test (LDT) in a US clinical microbiology laboratory.
  • Discuss how the MALDI-TOF based application for rapid ID direct from PBC can be used as a front-line method and how this approach can directly impact patient or institutional outcomes.
  • Describe how the MBT Sepsityper® result can directly influence the treatment path of a patient, especially when the MBT Sepsityper® ID result is reported with the Gram stain result.
  • Discuss how significant cost savings can be realized when MALDI-TOF and Molecular workflows are combined.
Only for sale in the United States and Puerto Rico.
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources